2015 Press/Media Releases:

Phase 3 Data Supporting Rayaldee™ As a Treatment for Secondary Hyperparathyroidism in
Chronic Kidney Disease to be Presented at NKF 2015 Spring Clinical Meetings

March 27, 2015

Phase 3 Data Supporting Rayaldee As a Treatment for Secondary Hyperparathyroidism in Chronic Kidney Disease to be Presented at ENDO 2015 Conference
March 6, 2015

 
     
     
 
   

© 2015 OPKO Health Inc.- All rights reserved. | Privacy Policy | Terms Of Use